Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00294034 · ClinicalTrials.gov registry record

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

A clinical trial of Bradycardia and Pacemaker, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
950
Enrollment target
20
Study locations

NCT00294034 is a study of Bradycardia and Pacemaker that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 950 participants, below the 4,380-participant average among 29 other Bradycardia trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00294034, a study of Bradycardia and Pacemaker, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
950 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.

Conditions Studied

Interventions

  • DEVICE Pacemaker

Study Locations (20)

Ohio

  • - Barberton
  • - Cincinnati
  • - Marion
  • - Massillon
  • - Middletown

Florida

  • - Fort Lauderdale
  • - Largo
  • - Ormond Beach
  • - St. Petersburg

Arkansas

  • - Hot Springs
  • - Little Rock
  • - North Little Rock

Kentucky

  • - Edgewood
  • - Louisville

New York

  • - Bay Shore
  • - Syracuse

Illinois

  • - Chicago

Massachusetts

  • - Hyannis

Michigan

  • - Lansing

Trial Details

FieldValue
Enrollment Target 950 participants
Start Date 2002-10
Est. Completion 2006-05

What the Registry Record Tells You About NCT00294034

The ClinicalTrials.gov registry entry for NCT00294034 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 950 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,380-participant average among 29 other Bradycardia trials with a reported enrollment target (78% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Pacemaker is the first listed.

NCT00294034 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Ohio, Florida, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00294034 about?

NCT00294034 is a clinical study titled "VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies". The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.

What is the current status of trial NCT00294034?

This trial is currently completed. The enrollment target is 950 participants. The study started on 2002-10. Estimated completion is 2006-05.

What conditions does trial NCT00294034 study?

This clinical trial studies the following conditions: Bradycardia, Pacemaker.

What interventions are being tested in trial NCT00294034?

The interventions under investigation include: Pacemaker (DEVICE).

Who is sponsoring clinical trial NCT00294034?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00294034 being conducted?

This trial has 20 study locations across Arkansas, Florida, Illinois, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.